A like-for-like ranking of where to get Multiple Sclerosis stem-cell therapy — by price, EU/GMP regulation and travel — with the honest verdict on value.
Direct answer: Across published 2026 data, Multiple Sclerosis stem-cell therapy runs roughly €4,140–€92,000 worldwide; the best value for Multiple Sclerosis is an EU/GMP clinic in Bulgaria (€3,000–8,000) — a quarter to a third of US, UK, German or Swiss pricing at the same European standard. There are 92 registered Multiple Sclerosis stem-cell trials on ClinicalTrials.gov (14 recruiting).
| Country | Indicative cost | Regulation | Notes |
|---|---|---|---|
| Bulgaria | €3,000–€8,000 | ✅ EU · GMP | Best EU value — GMP-certified, transparent fixed pricing, visa-free, short flights. |
| Germany | €15,000–€35,000 | ✅ EU · GMP | EU quality, but premium pricing and little price transparency. |
| Switzerland | €20,000–€40,000 | ✅ EU · GMP | Top reputation, highest prices in Europe. |
| India | €3,000–€8,000 | ✗ non-EU | Lowest absolute cost; non-EU and long-haul for Western patients. |
| Mexico | €3,000–€12,000 | ✗ non-EU | Affordable but non-EU; quality varies widely between clinics. |
| Turkey | €6,000–€18,000 | ✗ non-EU | Big medical-tourism hub; non-EU, variable regulation. |
| Thailand | €8,000–€20,000 | ✗ non-EU | Wellness-led; very long travel and non-EU. |
| Serbia | €7,000–€31,000 | ✗ non-EU | Popular (Swiss Medica) but non-EU and English-only. |
| UK | €14,000–€28,000 | ✗ non-EU | Very limited availability; long private wait. |
| Panama | €15,000–€27,000 | ✗ non-EU | Strong science reputation; long-haul and non-EU. |
| USA | €18,000–€35,000 | ✗ non-EU | Mostly experimental; insurance rarely covers regenerative therapy. |
Indicative ranges compiled from published clinic and medical-tourism pricing, 2026. Cost is only part of the decision — regulation, cell quality and the all-in travel cost matter as much.
On absolute price, India and Mexico are lowest (from ~€3,000), but both are non-EU with variable oversight. Bulgaria offers the lowest EU/GMP price (€3,000–8,000) — the cheapest regulated option.
Within the EU, Germany and Switzerland have strong reputations but premium pricing (€15,000–40,000). Bulgaria delivers the same EU GMP framework at €3,000–8,000 — the best EU value for Multiple Sclerosis.
It can be, if you choose a regulated clinic and compare the all-in cost (treatment + travel). Use our calculator, and always check whether a registered clinical trial is open first.
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
← Multiple Sclerosis: stem-cell overview · Multiple Sclerosis treatment options →
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment